Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 29 entries
Sorted by: Best Match Show Resources per page
Complexities in understanding and addressing the serious public health issues related to the nonmedical use of prescription drugs.

Addictive behaviors

Arria AM, Compton WM.
PMID: 27639956
Addict Behav. 2017 Feb;65:215-217. doi: 10.1016/j.addbeh.2016.09.002. Epub 2016 Sep 09.

No abstract available.

Cite
Arria AM, Compton WM. Complexities in understanding and addressing the serious public health issues related to the nonmedical use of prescription drugs. Addict Behav. 2016;65:215-217doi: 10.1016/j.addbeh.2016.09.002.
Arria, A. M., & Compton, W. M. (2017). Complexities in understanding and addressing the serious public health issues related to the nonmedical use of prescription drugs. Addictive behaviors, 65215-217. https://doi.org/10.1016/j.addbeh.2016.09.002
Arria, Amelia M, and Compton, Wilson M. "Complexities in understanding and addressing the serious public health issues related to the nonmedical use of prescription drugs." Addictive behaviors vol. 65 (2017): 215-217. doi: https://doi.org/10.1016/j.addbeh.2016.09.002
Arria AM, Compton WM. Complexities in understanding and addressing the serious public health issues related to the nonmedical use of prescription drugs. Addict Behav. 2017 Feb;65:215-217. doi: 10.1016/j.addbeh.2016.09.002. Epub 2016 Sep 09. PMID: 27639956; PMCID: PMC5140704.
Copy Download .nbib Format: NLM
Myristic acid hitchhiking on sigma-1 receptor to fend off neurodegeneration.

Receptors & clinical investigation

Ciesielski J, Su TP, Tsai SY.
PMID: 27077074
Receptors Clin Investig. 2016;3(1). doi: 10.14800/rci.1114.

Neurodegenerative diseases are linked to tauopathy as a result of cyclin dependent kinase 5 (cdk5) binding to its p25 activator instead of its p35 activator and becoming over-activated. The overactive complex stimulates the hyperphosphorylation of tau proteins, leading to...

Cite
Ciesielski J, Su TP, Tsai SY. Myristic acid hitchhiking on sigma-1 receptor to fend off neurodegeneration. Receptors Clin Investig. 2016;3(1)doi: 10.14800/rci.1114.
Ciesielski, J., Su, T. P., & Tsai, S. Y. (2016). Myristic acid hitchhiking on sigma-1 receptor to fend off neurodegeneration. Receptors & clinical investigation, 3(1), . https://doi.org/10.14800/rci.1114
Ciesielski, Jenna, et al. "Myristic acid hitchhiking on sigma-1 receptor to fend off neurodegeneration." Receptors & clinical investigation vol. 3,1 (2016). doi: https://doi.org/10.14800/rci.1114
Ciesielski J, Su TP, Tsai SY. Myristic acid hitchhiking on sigma-1 receptor to fend off neurodegeneration. Receptors Clin Investig. 2016;3(1). doi: 10.14800/rci.1114. PMID: 27077074; PMCID: PMC4827442.
Copy Download .nbib Format: NLM
Neuroepigenomics: Resources, Obstacles, and Opportunities.

Neuroepigenetics

Satterlee JS, Beckel-Mitchener A, Little R, Procaccini D, Rutter JL, Lossie AC.
PMID: 25722961
Neuroepigenetics. 2015 Jan 01;1:2-13. doi: 10.1016/j.nepig.2014.10.001.

Long-lived post-mitotic cells, such as the majority of human neurons, must respond effectively to ongoing changes in neuronal stimulation or microenvironmental cues through transcriptional and epigenomic regulation of gene expression. The role of epigenomic regulation in neuronal function is...

Cite
Satterlee JS, Beckel-Mitchener A, Little R, et al. Neuroepigenomics: Resources, Obstacles, and Opportunities. Neuroepigenetics. 2015;1:2-13doi: 10.1016/j.nepig.2014.10.001.
Satterlee, J. S., Beckel-Mitchener, A., Little, R., Procaccini, D., Rutter, J. L., & Lossie, A. C. (2015). Neuroepigenomics: Resources, Obstacles, and Opportunities. Neuroepigenetics, 12-13. https://doi.org/10.1016/j.nepig.2014.10.001
Satterlee, John S, et al. "Neuroepigenomics: Resources, Obstacles, and Opportunities." Neuroepigenetics vol. 1 (2015): 2-13. doi: https://doi.org/10.1016/j.nepig.2014.10.001
Satterlee JS, Beckel-Mitchener A, Little R, Procaccini D, Rutter JL, Lossie AC. Neuroepigenomics: Resources, Obstacles, and Opportunities. Neuroepigenetics. 2015 Jan 01;1:2-13. doi: 10.1016/j.nepig.2014.10.001. PMID: 25722961; PMCID: PMC4337407.
Copy Download .nbib Format: NLM
Reenvisioning Clinical Science: Unifying the Discipline to Improve the Public Health.

Clinical psychological science : a journal of the Association for Psychological Science

Onken LS, Carroll KM, Shoham V, Cuthbert BN, Riddle M.
PMID: 25821658
Clin Psychol Sci. 2014 Jan 01;2(1):22-34. doi: 10.1177/2167702613497932.

We present a vision of clinical science, based on a conceptual framework of intervention development endorsed by the Delaware Project. This framework is grounded in an updated stage model that incorporates basic science questions of mechanisms into every stage...

Cite
Onken LS, Carroll KM, Shoham V, et al. Reenvisioning Clinical Science: Unifying the Discipline to Improve the Public Health. Clin Psychol Sci. 2014;2(1):22-34doi: 10.1177/2167702613497932.
Onken, L. S., Carroll, K. M., Shoham, V., Cuthbert, B. N., & Riddle, M. (2014). Reenvisioning Clinical Science: Unifying the Discipline to Improve the Public Health. Clinical psychological science : a journal of the Association for Psychological Science, 2(1), 22-34. https://doi.org/10.1177/2167702613497932
Onken, Lisa S, et al. "Reenvisioning Clinical Science: Unifying the Discipline to Improve the Public Health." Clinical psychological science : a journal of the Association for Psychological Science vol. 2,1 (2014): 22-34. doi: https://doi.org/10.1177/2167702613497932
Onken LS, Carroll KM, Shoham V, Cuthbert BN, Riddle M. Reenvisioning Clinical Science: Unifying the Discipline to Improve the Public Health. Clin Psychol Sci. 2014 Jan 01;2(1):22-34. doi: 10.1177/2167702613497932. PMID: 25821658; PMCID: PMC4374633.
Copy Download .nbib Format: NLM
In vitro and in vivo human metabolism of a new synthetic cannabinoid NM-2201 (CBL-2201).

Forensic toxicology

Diao X, Carlier J, Zhu M, Pang S, Kronstrand R, Scheidweiler KB, Huestis MA.
PMID: 28286577
Forensic Toxicol. 2017 Jan;35(1):20-32. doi: 10.1007/s11419-016-0326-9. Epub 2016 Jul 06.

In 2014, NM-2201 (CBL-2201), a novel synthetic cannabinoid (SC), was detected by Russian and United States laboratories. It was already added to the scheduled drugs list in Japan, Sweden and Germany. Unfortunately, no human metabolism data are currently available,...

Cite
Diao X, Carlier J, Zhu M, et al. In vitro and in vivo human metabolism of a new synthetic cannabinoid NM-2201 (CBL-2201). Forensic Toxicol. 2016;35(1):20-32doi: 10.1007/s11419-016-0326-9.
Diao, X., Carlier, J., Zhu, M., Pang, S., Kronstrand, R., Scheidweiler, K. B., & Huestis, M. A. (2017). In vitro and in vivo human metabolism of a new synthetic cannabinoid NM-2201 (CBL-2201). Forensic toxicology, 35(1), 20-32. https://doi.org/10.1007/s11419-016-0326-9
Diao, Xingxing, et al. "In vitro and in vivo human metabolism of a new synthetic cannabinoid NM-2201 (CBL-2201)." Forensic toxicology vol. 35,1 (2017): 20-32. doi: https://doi.org/10.1007/s11419-016-0326-9
Diao X, Carlier J, Zhu M, Pang S, Kronstrand R, Scheidweiler KB, Huestis MA. In vitro and in vivo human metabolism of a new synthetic cannabinoid NM-2201 (CBL-2201). Forensic Toxicol. 2017 Jan;35(1):20-32. doi: 10.1007/s11419-016-0326-9. Epub 2016 Jul 06. PMID: 28286577; PMCID: PMC5342258.
Copy Download .nbib Format: NLM
Improving drug abuse treatment delivery through adoption of harmonized electronic health record systems.

Substance abuse and rehabilitation

Ghitza UE, Sparenborg S, Tai B.
PMID: 21822398
Subst Abuse Rehabil. 2011 Jul 01;2011(2):125-131. doi: 10.2147/SAR.S23030.

A great divide currently exists between mainstream health care and specialty substance use disorders (SUD) treatment, concerning the coordination of care and sharing of medical information. Improving the coordination of SUD treatment with other disciplines of medicine will benefit...

Cite
Ghitza UE, Sparenborg S, Tai B. Improving drug abuse treatment delivery through adoption of harmonized electronic health record systems. Subst Abuse Rehabil. 2011;2011(2):125-131doi: 10.2147/SAR.S23030.
Ghitza, U. E., Sparenborg, S., & Tai, B. (2011). Improving drug abuse treatment delivery through adoption of harmonized electronic health record systems. Substance abuse and rehabilitation, 2011(2), 125-131. https://doi.org/10.2147/SAR.S23030
Ghitza, Udi E, et al. "Improving drug abuse treatment delivery through adoption of harmonized electronic health record systems." Substance abuse and rehabilitation vol. 2011,2 (2011): 125-131. doi: https://doi.org/10.2147/SAR.S23030
Ghitza UE, Sparenborg S, Tai B. Improving drug abuse treatment delivery through adoption of harmonized electronic health record systems. Subst Abuse Rehabil. 2011 Jul 01;2011(2):125-131. doi: 10.2147/SAR.S23030. PMID: 21822398; PMCID: PMC3149797.
Copy Download .nbib Format: NLM
Integrating substance abuse care with community diabetes care: implications for research and clinical practice.

Substance abuse and rehabilitation

Ghitza UE, Wu LT, Tai B.
PMID: 23378792
Subst Abuse Rehabil. 2013 Jan 01;4:3-10. doi: 10.2147/SAR.S39982. Epub 2013 Jan 11.

Cigarette smoking and alcohol use are prevalent among individuals with diabetes in the US, but little is known about screening and treatment for substance use disorders in the diabetic population. This commentary discusses the scope and clinical implications of...

Cite
Ghitza UE, Wu LT, Tai B. Integrating substance abuse care with community diabetes care: implications for research and clinical practice. Subst Abuse Rehabil. 2013;4:3-10doi: 10.2147/SAR.S39982.
Ghitza, U. E., Wu, L. T., & Tai, B. (2013). Integrating substance abuse care with community diabetes care: implications for research and clinical practice. Substance abuse and rehabilitation, 43-10. https://doi.org/10.2147/SAR.S39982
Ghitza, Udi E, et al. "Integrating substance abuse care with community diabetes care: implications for research and clinical practice." Substance abuse and rehabilitation vol. 4 (2013): 3-10. doi: https://doi.org/10.2147/SAR.S39982
Ghitza UE, Wu LT, Tai B. Integrating substance abuse care with community diabetes care: implications for research and clinical practice. Subst Abuse Rehabil. 2013 Jan 01;4:3-10. doi: 10.2147/SAR.S39982. Epub 2013 Jan 11. PMID: 23378792; PMCID: PMC3558925.
Copy Download .nbib Format: NLM
Implementing drug abuse treatment services in criminal justice settings: Introduction to the CJ-DATS study protocol series.

Health & justice

Ducharme LJ, Chandler RK, Wiley TR.
PMID: 24707454
Health Justice. 2013 Dec 01;1(1):5. doi: 10.1186/2194-7899-1-5.

BACKGROUND: Despite a growing pipeline of effective clinical treatments, there remains a persistent research-to-practice gap in drug abuse services. Delivery of effective treatment services is especially lacking in the U.S. criminal justice system, where half of all incarcerated persons...

Cite
Ducharme LJ, Chandler RK, Wiley TR. Implementing drug abuse treatment services in criminal justice settings: Introduction to the CJ-DATS study protocol series. Health Justice. 2013;1(1):5doi: 10.1186/2194-7899-1-5.
Ducharme, L. J., Chandler, R. K., & Wiley, T. R. (2013). Implementing drug abuse treatment services in criminal justice settings: Introduction to the CJ-DATS study protocol series. Health & justice, 1(1), 5. https://doi.org/10.1186/2194-7899-1-5
Ducharme, Lori J, et al. "Implementing drug abuse treatment services in criminal justice settings: Introduction to the CJ-DATS study protocol series." Health & justice vol. 1,1 (2013): 5. doi: https://doi.org/10.1186/2194-7899-1-5
Ducharme LJ, Chandler RK, Wiley TR. Implementing drug abuse treatment services in criminal justice settings: Introduction to the CJ-DATS study protocol series. Health Justice. 2013 Dec 01;1(1):5. doi: 10.1186/2194-7899-1-5. PMID: 24707454; PMCID: PMC3975625.
Copy Download .nbib Format: NLM
Development of Focused Transcranial Magnetic Stimulation for Rodents by Copper-Array Shields.

IEEE transactions on magnetics

Meng Q, Cherry M, Refai A, Du X, Lu H, Hong E, Yang Y, Choa FS.
PMID: 30344336
IEEE Trans Magn. 2018 May;54(5). doi: 10.1109/TMAG.2018.2796098. Epub 2018 Feb 14.

Transcranial magnetic stimulation (TMS) is one of the most widely used noninvasive brain stimulation method. It has been utilized for both treatment and diagnosis of many neural diseases, such as neuropathic pain and loss of function caused by stroke....

Cite
Meng Q, Cherry M, Refai A, et al. Development of Focused Transcranial Magnetic Stimulation for Rodents by Copper-Array Shields. IEEE Trans Magn. 2018;54(5)doi: 10.1109/TMAG.2018.2796098.
Meng, Q., Cherry, M., Refai, A., Du, X., Lu, H., Hong, E., Yang, Y., & Choa, F. S. (2018). Development of Focused Transcranial Magnetic Stimulation for Rodents by Copper-Array Shields. IEEE transactions on magnetics, 54(5), . https://doi.org/10.1109/TMAG.2018.2796098
Meng, Qinglei, et al. "Development of Focused Transcranial Magnetic Stimulation for Rodents by Copper-Array Shields." IEEE transactions on magnetics vol. 54,5 (2018). doi: https://doi.org/10.1109/TMAG.2018.2796098
Meng Q, Cherry M, Refai A, Du X, Lu H, Hong E, Yang Y, Choa FS. Development of Focused Transcranial Magnetic Stimulation for Rodents by Copper-Array Shields. IEEE Trans Magn. 2018 May;54(5). doi: 10.1109/TMAG.2018.2796098. Epub 2018 Feb 14. PMID: 30344336; PMCID: PMC6193565.
Copy Download .nbib Format: NLM
Potential Molecular Mechanisms on the Role of the Sigma-1 Receptor in the Action of Cocaine and Methamphetamine.

Journal of drug and alcohol research

Yasui Y, Su TP.
PMID: 27088037
J Drug Alcohol Res. 2016 Feb 20;5. doi: 10.4303/jdar/235970.

The sigma-1 receptor (Sig-1R) is an endoplasmic reticulum membrane protein that involves a wide range of physiological functions. The Sig-1R has been shown to bind psychostimulants including cocaine and methamphetamine (METH) and thus has been implicated in the actions...

Cite
Yasui Y, Su TP. Potential Molecular Mechanisms on the Role of the Sigma-1 Receptor in the Action of Cocaine and Methamphetamine. J Drug Alcohol Res. 2016;5doi: 10.4303/jdar/235970.
Yasui, Y., & Su, T. P. (2016). Potential Molecular Mechanisms on the Role of the Sigma-1 Receptor in the Action of Cocaine and Methamphetamine. Journal of drug and alcohol research, 5. https://doi.org/10.4303/jdar/235970
Yasui, Yuko, and Su, Tsung-Ping. "Potential Molecular Mechanisms on the Role of the Sigma-1 Receptor in the Action of Cocaine and Methamphetamine." Journal of drug and alcohol research vol. 5 (2016). doi: https://doi.org/10.4303/jdar/235970
Yasui Y, Su TP. Potential Molecular Mechanisms on the Role of the Sigma-1 Receptor in the Action of Cocaine and Methamphetamine. J Drug Alcohol Res. 2016 Feb 20;5. doi: 10.4303/jdar/235970. PMID: 27088037; PMCID: PMC4830437.
Copy Download .nbib Format: NLM
Emotional arousal enhances word repetition priming.

Cognition & emotion

Thomas LA, LaBar KS.
PMID: 26321783
Cogn Emot. 2005;19(7):1027-1047. doi: 10.1080/02699930500172440.

Three experiments were conducted to determine if emotional content increases repetition priming magnitude. In the study phase of Experiment 1, participants rated high-arousing negative (taboo) words and neutral words for concreteness. In the test phase, they made lexical decision...

Cite
Thomas LA, LaBar KS. Emotional arousal enhances word repetition priming. Cogn Emot. 2005;19(7):1027-1047doi: 10.1080/02699930500172440.
Thomas, L. A., & LaBar, K. S. (2005). Emotional arousal enhances word repetition priming. Cognition & emotion, 19(7), 1027-1047. https://doi.org/10.1080/02699930500172440
Thomas, Laura A, and LaBar, Kevin S. "Emotional arousal enhances word repetition priming." Cognition & emotion vol. 19,7 (2005): 1027-1047. doi: https://doi.org/10.1080/02699930500172440
Thomas LA, LaBar KS. Emotional arousal enhances word repetition priming. Cogn Emot. 2005;19(7):1027-1047. doi: 10.1080/02699930500172440. PMID: 26321783; PMCID: PMC4551502.
Copy Download .nbib Format: NLM
Incretin Mimetics as Rational Candidates for the Treatment of Traumatic Brain Injury.

ACS pharmacology & translational science

Glotfelty EJ, Delgado T, Tovar-Y-Romo LB, Luo Y, Hoffer B, Olson L, Karlsson T, Mattson MP, Harvey B, Tweedie D, Li Y, Greig NH.
PMID: 31396586
ACS Pharmacol Transl Sci. 2019 Apr 12;2(2):66-91. doi: 10.1021/acsptsci.9b00003. Epub 2019 Feb 11.

Traumatic brain injury (TBI) is becoming an increasing public health issue. With an annually estimated 1.7 million TBIs in the United States (U.S) and nearly 70 million worldwide, the injury, isolated or compounded with others, is a major cause...

Cite
Glotfelty EJ, Delgado T, Tovar-Y-Romo LB, et al. Incretin Mimetics as Rational Candidates for the Treatment of Traumatic Brain Injury. ACS Pharmacol Transl Sci. 2019;2(2):66-91doi: 10.1021/acsptsci.9b00003.
Glotfelty, E. J., Delgado, T., Tovar-Y-Romo, L. B., Luo, Y., Hoffer, B., Olson, L., Karlsson, T., Mattson, M. P., Harvey, B., Tweedie, D., Li, Y., & Greig, N. H. (2019). Incretin Mimetics as Rational Candidates for the Treatment of Traumatic Brain Injury. ACS pharmacology & translational science, 2(2), 66-91. https://doi.org/10.1021/acsptsci.9b00003
Glotfelty, Elliot J, et al. "Incretin Mimetics as Rational Candidates for the Treatment of Traumatic Brain Injury." ACS pharmacology & translational science vol. 2,2 (2019): 66-91. doi: https://doi.org/10.1021/acsptsci.9b00003
Glotfelty EJ, Delgado T, Tovar-Y-Romo LB, Luo Y, Hoffer B, Olson L, Karlsson T, Mattson MP, Harvey B, Tweedie D, Li Y, Greig NH. Incretin Mimetics as Rational Candidates for the Treatment of Traumatic Brain Injury. ACS Pharmacol Transl Sci. 2019 Apr 12;2(2):66-91. doi: 10.1021/acsptsci.9b00003. Epub 2019 Feb 11. PMID: 31396586; PMCID: PMC6687335.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 29 entries